Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study.
Muratore F, Marvisi C, Castrignanò P, Croci S, Bonacini M, Boiardi L, Ricordi C, Galli E, Besutti G, Spaggiari L, Versari A, Giorgi Rossi P, Pipitone N, Salvarani C.
Muratore F, et al. Among authors: pipitone n.
Semin Arthritis Rheum. 2024 Feb;64:152351. doi: 10.1016/j.semarthrit.2023.152351. Epub 2023 Dec 20.
Semin Arthritis Rheum. 2024.
PMID: 38142617